A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
Open Access
- 16 November 2018
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-16
Abstract
Antiretroviral therapy (ART) suppresses viral replication in people living with HIV. Yet, infected cells persist for decades on ART and viremia returns if ART is stopped. Persistence has been attributed to viral replication in an ART sanctuary and long-lived and/or proliferating latently infected cells. Using ecological methods and existing data, we infer that >99% of infected cells are members of clonal populations after one year of ART. We reconcile our results with observations from the first months of ART, demonstrating mathematically how a fossil record of historic HIV replication permits observed viral evolution even while most new infected cells arise from proliferation. Together, our results imply cellular proliferation generates a majority of infected cells during ART. Therefore, reducing proliferation could decrease the size of the HIV reservoir and help achieve a functional cure.Keywords
All Related Versions
Funding Information
- Washington Research Foundation (Postdoctoral Fellowship)
- National Center for Advancing Translational Sciences (KL2 TR002317)
- National Institute of Allergy and Infectious Diseases (P01 AI030371-24, U19 AI113173-02, R01 AI121129-01, UM1 AI126623, UM1 AI068635)
This publication has 75 references indexed in Scilit:
- Within-host and between-host evolutionary rates across the HIV-1 genomeRetrovirology, 2013
- Reconstructing the Dynamics of HIV Evolution within Hosts from Serial Deep Sequence DataPLOS Computational Biology, 2012
- Estimation of the Initial Viral Growth Rate and Basic Reproductive Number during Acute HIV-1 InfectionJournal of Virology, 2010
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNature Medicine, 2009
- Monotypic Human Immunodeficiency Virus Type 1 Genotypes across the Uterine Cervix and in Blood Suggest Proliferation of Cells with ProvirusJournal of Virology, 2009
- HIV rebounds from latently infected cells, rather than from continuing low-level replicationProceedings of the National Academy of Sciences, 2008
- Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapyProceedings of the National Academy of Sciences, 2008
- Hierarchical Bayesian Methods for Estimation of Parameters in a Longitudinal HIV Dynamic SystemBiometrics, 2005
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996